|
|
|
24.04.25 - 10:18
|
Mitsubishi Chemical to Quit Fiber Dyeing Biz (Nippon)
|
|
|
Tokyo, April 24 (Jiji Press)--Mitsubishi Chemical Corp. said Thursday that it will withdraw from all operations of Tosen Co., a unit that dyes wigs and synthetic and natural fibers. Tosen, based in Osaka Prefecture, western Japan, is expected to cease production and sales by the end of March 2026 in response to weak demand in the fiber dyeing business, its core operations. Mitsubishi Chem......
|
|
|
|
|
|
|
07.02.25 - 14:48
|
Mitsubishi Chemical to Sell Drug Unit to Bain Capital (Nippon)
|
|
|
Tokyo, Feb. 7 (Jiji Press)--Mitsubishi Chemical Group Corp. said Friday that it will sell subsidiary Mitsubishi Tanabe Pharma Corp. to U.S. investment firm Bain Capital LP. for about 510 billion yen. Through the sale, which is expected to be completed by September, the Japanese group plans to focus on its core chemical business, including materials related to semiconductors. Meanwhile, the d......
|
|
|
|
|
07.02.25 - 12:03
|
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation (Business Wire)
|
|
|
Independent company plans significant investment in innovation, both internal product development and external licensing and acquisitions, supported by Bain Capital investmentTOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (“Tanabe Pharma”, “MTPC” or “the Company”) in a carve-out transaction from Mitsubishi Chemical Group Corporation. The investment is being led by Bain Capital's Private Equity teams in Asia and North America together with the firm's Life Sciences team and values the business at approximately 510 billion JPY (3.3 billion USD).
Founded in 1678, Tanabe Pharma is headquartered in Doshomachi, Osaka, the birthplace of Japan's pharmaceutical industry. Through the discovery and development of innovative drugs that address unmet medical needs, MTPC focuses on several priority therapeutic areas, including immunology & inflammation, vaccines, c...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.12.24 - 11:49
|
Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 bln deal, sources say (Reuters EN)
|
|
|
Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 bln deal, sources say By Kane Wu HONG KONG, Dec 13 (Reuters) - Global private equity firms Blackstone BX.N and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan's Mitsubishi Chemical Group, in a deal that could value it at between $3 billion and $3.5 billion, three sources said....
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
